Nuvaring (Ethinyl Estradiol Etonogestrel)

Additional information

Nuvaring (Ethinyl Estradiol Etonogestrel) is typically used as one ring, inserted vaginally and left in place continuously for 3 consecutive weeks, then removed for 1 week. However, your doctor or pharmacist may have suggested a different schedule that is more appropriate for you. Important: Follow the instructions on the label. Do not use more of this product, or more often, than prescribed. A new ring is inserted 7 days after the last was removed (even if bleeding is not complete) and should be inserted at approximately the same time of day the ring was removed the previous week.
WARNING: Use with caution in patients with risk factors for heart disease, history of depression, diabetes. Not for use prior to menarche. Use is not indicated in postmenopausal women. In addition to its desired action, Nuvaring (Ethinyl Estradiol Etonogestrel) may cause some side effects, notably:
It may cause headaches, vaginitis (an inflammation of the vagina), mood changes, acne vulgaris It may cause weight gain, decreased libido, nausea, vomiting, abdominal pain It may cause vaginal discharge, vaginal discomfort, breast tenderness Contraindications: Hypersensitivity, to ethinyl estradiol, etonogestrel, or any component of the formulation, breast cancer or other estrogen- or progestin-sensitive cancer, liver cancer or liver disease, pregnancy, undiagnosed abnormal uterine bleeding, concurrent use of hepatitis C (liver disease) drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir. Use is also contraindicated in women at high risk of vascular disease (any condition that affects the network of your blood vessels), diabetes mellitus with any of the following: age >35 years, duration >20 years, hypertension (high blood pressure), vascular disease, or other end-organ damage (damage occurring in major organs fed by the circulatory system (heart, kidneys, brain, eyes)), deep vein thrombosis (blood clots in deep veins usually legs) or blockage in one of the pulmonary arteries in the lungs, abnormally increased tendency toward blood clotting (coagulation), uncontrolled high blood pressure (hypertension), migraine headaches with any of the following: age >35 years, aura (flashes of light, blind spots, and other vision changes or tingling in your hand or face), or focal neurological symptoms (impairments of nerve, spinal cord, or brain function that affects a specific region of the body), cardiac (heart) problems, smoking if >35 years of age.
Taking Nuvaring (Ethinyl Estradiol Etonogestrel) during pregnancy is contraindicated and harmful for the baby. Combination hormonal contraceptives are used to prevent pregnancy, treatment should be discontinued if pregnancy occurs. Pregnant women should not use this product. If you're planning a pregnancy or become pregnant or breastfeeding, contact your family doctor. A treatment with Nuvaring (Ethinyl Estradiol Etonogestrel) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Nuvaring (Ethinyl Estradiol Etonogestrel)